| SC 13G/A | 2024-02-09 | AFFIRIS AG in Liqu | AC Immune SA | 6,578,100 | 6.7% | EDGAR |
| SC 13G/A | 2023-12-19 | BIOTECHNOLOGY VALUE FUND L P | AC Immune SA | 7,650,259 | 7.7% | EDGAR |
| SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | AC Immune SA | 3,980,659 | 4.8% | EDGAR |
| SC 13G/A | 2023-02-14 | AFFIRIS AG in Liqu | AC Immune SA | 6,724,840 | 8.1% | EDGAR |
| SC 13G/A | 2023-02-10 | dievini Hopp BioTech holding GmbH & Co KG | AC Immune SA | 16,316,742 | 19.5% | EDGAR |
| SC 13G/A | 2023-01-27 | ELI LILLY & Co | AC Immune SA | 3,615,328 | 4.3% | EDGAR |
| SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | AC Immune SA | 3,648,633 | 5.0% | EDGAR |
| SC 13G/A | 2022-02-14 | EcoR1 Capital, LLC | AC Immune SA | 749,585 | 0.9% | EDGAR |
| SC 13G | 2021-08-05 | AFFiRiS AG | AC Immune SA | 7,106,840 | 8.5% | EDGAR |
| SC 13G/A | 2021-02-12 | dievini Hopp BioTech holding GmbH & Co KG | AC Immune SA | 18,041,000 | 25.1% | EDGAR |
| SC 13G | 2021-02-12 | ELI LILLY & Co | AC Immune SA | 3,615,328 | 5.0% | EDGAR |
| SC 13G | 2021-01-22 | EcoR1 Capital, LLC | AC Immune SA | 4,702,160 | 6.6% | EDGAR |
| SC 13G/A | 2021-01-14 | BIOTECHNOLOGY VALUE FUND L P | AC Immune SA | 4,178,515 | 5.8% | EDGAR |
| SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | AC Immune SA | 5,605,420 | 8.3% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | AC Immune SA | 67,457 | 0.1% | EDGAR |
| SC 13G/A | 2020-02-06 | dievini Hopp BioTech holding GmbH & Co KG | AC Immune SA | 18,041,000 | 26.7% | EDGAR |
| SC 13G/A | 2019-09-16 | BIOTECHNOLOGY VALUE FUND L P | AC Immune SA | 5,580,788 | 8.3% | EDGAR |
| SC 13G/A | 2019-03-21 | BIOTECHNOLOGY VALUE FUND L P | AC Immune SA | 3,574,717 | 5.3% | EDGAR |
| SC 13G/A | 2019-02-13 | FMR LLC | AC Immune SA | 5,612,758 | 8.3% | EDGAR |
| SC 13G/A | 2019-02-12 | Varuma AG | AC Immune SA | 11,999,999 | 17.8% | EDGAR |